Poliomyelitis clinical trials

The registry lists 222 studies for Poliomyelitis across more than 10 countries. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.

Studies

Recruiting first, then most recently updated. Showing 50 of 222 — search for more.

• A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated InfantsRecruitingNCT07010822Phase 31 country
• Study of BK1803 in Healthy InfantsNot yet recruitingNCT07793513Phase 31 country
• Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy AdultsNot yet recruitingNCT07688369Phase 11 country
• Study of a Novel Type 3 Oral Poliomyelitis Vaccine in PanamaRecruitingNCT05654467Phase 21 country
• Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus VaccineRecruitingNCT07457060Phase 41 country
• Phase IV Clinical Study of sIPV Administration in Adolescent and Adult PopulationsRecruitingNCT07354269Phase 41 country
• the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L VaccinesNot yet recruitingNCT073388511 country
• Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines EvaluationRecruitingNCT06895486Phase 21 country
• Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis VaccinesRecruitingNCT06137664Phase 1/21 country
• Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of AgeNot yet recruitingNCT06618196Phase 2
• A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy AdultsNot yet recruitingNCT05952596Phase 1
• Study of a Novel Type 1 Oral Poliomyelitis Vaccine in BangladeshCompletedNCT05644184Phase 21 country
• Effects of Virtual Walking on Chronic Pain and Psychological Distress for Individuals With Severe Mobility ImpairmentActive, not recruitingNCT07820618Not applicable1 country
• Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary SeriesCompletedNCT05457946Phase 2/31 country
• A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2CompletedNCT05677256Phase 41 country
• A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesActive, not recruitingNCT06947499Phase 2/31 country
• A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and ToddlersActive, not recruitingNCT06577298Phase 1/21 country
• Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021CompletedNCT049393501 country
• The Impact of 'Digital Strolling' on Depression and Quality of Life of People With Severe Mobility ImpairmentCompletedNCT07073144Not applicable1 country
• Booster Dose of sIPV Co-administered With MMR and HepA-I.CompletedNCT06442449Phase 41 country
• Confirmatory Study of BK1310 in Healthy InfantsCompletedNCT03891758Phase 31 country
• Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)CompletedNCT07297186Phase 31 country
• A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV VaccineCompletedNCT05850364Phase 32 countries
• High Intensity Functional Training for Individuals With Neurologic Diagnoses and Their Care PartnersCompletedNCT05951985Not applicable1 country
• Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control OrthosisActive, not recruitingNCT02089880Not applicable1 country
• Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in InfantsCompletedNCT05431933Phase 32 countries
• Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus VaccineCompletedNCT05460377Phase 41 country
• Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different ManufacturersCompletedNCT06346834Phase 41 country
• A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old InfantsCompletedNCT06752174Phase 31 country
• A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy AdultsCompletedNCT06101173Phase 11 country
• Study of Novel Types 1 and 3 Oral Poliomyelitis VaccinesCompletedNCT04529538Phase 11 country
• Immunogenicity nOPV2 With and Without bOPVCompletedNCT04579510Phase 21 country
• Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in InfantsCompletedNCT05033561Phase 31 country
• Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)CompletedNCT04481191Phase 31 country
• Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio VaccineCompletedNCT00137696Not applicable1 country
• Community Engagement and Conditional Incentives to Accelerate PolioCompletedNCT05721274Not applicable1 country
• Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old InfantsCompletedNCT05386810Phase 31 country
• Evaluation of Fatigue Severity, Mood, and Quality of Life in Post-Polio SyndromeCompletedNCT061621041 country
• A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio VaccineCompletedNCT03554798Phase 21 country
• Intradermal Fractional Dose IPV (fIPV) in Combination With dmLTActive, not recruitingNCT05327426Phase 11 country
• Immunogenicity of After Primary Immunization and Booster Immunization of sIPVActive, not recruitingNCT060584291 country
• Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus VaccineCompletedNCT05163561Phase 31 country
• Inactivated Poliomyelitis Vaccine Made From Sabin StrainCompletedNCT04220515Phase 41 country
• Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPVCompletedNCT03614702Phase 31 country
• Consistency Study for Three Commercial Lots of Inactivated Poliomyelitis Vaccine Made From Sabin StrainCompletedNCT04224519Phase 41 country
• The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)CompletedNCT01510366Phase 31 country
• The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)CompletedNCT02231632Phase 2/31 country
• Effect of Lactoferrin on Polio SeroconversionCompletedNCT04432935Not applicable1 country
• A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPVCompletedNCT03239496Phase 32 countries
• Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruSCompletedNCT02458183Phase 32 countries